Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
Edwards Lifesciences Deferred Tax Assets and Other Non-Current Assets increased by 1.2% to $738.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $742.70M to $738.90M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 43.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $105.30M | $133.70M | $110.80M | $129.40M | $234.70M | $316.50M | $299.10M | $293.60M | $412.10M | $447.40M | $463.20M | $767.60M | $789.80M | $683.50M | $721.60M | $742.70M | $743.00M | $784.80M | $730.20M | $738.90M |
| QoQ Change | — | +27.0% | -17.1% | +16.8% | +81.4% | +34.9% | -5.5% | -1.8% | +40.4% | +8.6% | +3.5% | +65.7% | +2.9% | -13.5% | +5.6% | +2.9% | +0.0% | +5.6% | -7.0% | +1.2% |
| YoY Change | — | — | — | — | +122.9% | +136.7% | +169.9% | +126.9% | +75.6% | +41.4% | +54.9% | +161.4% | +91.7% | +52.8% | +55.8% | -3.2% | -5.9% | +14.8% | +1.2% | -0.5% |
Range$105.30M – $789.80M
CAGR+50.7%
Avg YoY Growth+68.5%
Median YoY Growth+55.3%
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's deferred tax assets and other non-current assets?
- Edwards Lifesciences (EW) reported deferred tax assets and other non-current assets of $738.90M in Q1 2026.
- How has Edwards Lifesciences's deferred tax assets and other non-current assets changed year-over-year?
- Edwards Lifesciences's deferred tax assets and other non-current assets decreased by 0.5% year-over-year, from $742.70M to $738.90M.
- What is the long-term trend for Edwards Lifesciences's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's deferred tax assets and other non-current assets has grown at a 43.6% compound annual growth rate (CAGR), from $119.60M to $730.20M.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.